Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ML
|
Matthew Derella
Director |
BUY
Open market or private purchase
|
Direct | 123,243 Added 41.87% |
$253,881
$2.06 p/Share
|
Mar 15
2022 |
|
WINT
|
Craig Fraser
President and CEO |
BUY
Open market or private purchase
|
Direct | 3,000 Added 1.42% |
$2,940
$0.98 p/Share
|
Mar 15
2022 |
|
WINT
|
Steven Simonson
SVP, Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 5,000 Added 5.64% |
$5,000
$1.0 p/Share
|
Mar 15
2022 |
|
HVBC
|
Robert Joseph Marino
Vice-Chair and President |
BUY
Open market or private purchase
|
Indirect | 265 Added 0.34% |
$5,592
$21.1 p/Share
|
Mar 15
2022 |
|
QNTO
|
James J Clarke
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,000 Added 1.56% |
$13,300
$13.3 p/Share
|
Mar 15
2022 |
|
SFT
|
Oded Shein
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 15,087 Reduced 4.89% |
$29,118
$1.93 p/Share
|
Mar 15
2022 |
|
SLNG
|
Benjamin J. Broussard
Director |
BUY
Open market or private purchase
|
Direct | 1,500 Added 33.33% |
$6,000
$4.0 p/Share
|
Mar 15
2022 |
|
SLNG
|
Jch Crenshaw Holdings, LLC
Director |
BUY
Open market or private purchase
|
Direct | 218,843 Added 42.15% |
$945,402
$4.32 p/Share
|
Mar 15
2022 |
|
ALZN
|
Lynne Fahey Mc Grath |
BUY
Exercise of conversion of derivative security
|
Direct | 50,000 Added 33.33% |
-
|
Mar 15
2022 |
|
ALZN
|
Mark Gustafson |
BUY
Exercise of conversion of derivative security
|
Direct | 50,000 Added 38.46% |
-
|
Mar 15
2022 |
|
OCX
|
Mitchell S Levine
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 25,000 Added 22.31% |
$29,250
$1.17 p/Share
|
Mar 15
2022 |
|
CPS
|
Somasundhar Venkatasubramanian
Officer |
BUY
Open market or private purchase
|
Direct | 2,250 Added 37.96% |
$19,462
$8.65 p/Share
|
Mar 15
2022 |
|
IMRX
|
Ann E Berman
Director |
BUY
Open market or private purchase
|
Direct | 6,000 Added 38.71% |
$38,400
$6.4 p/Share
|
Mar 15
2022 |
|
AOUT
|
Mary E Gallagher |
BUY
Open market or private purchase
|
Direct | 3,671 Added 14.19% |
$49,962
$13.61 p/Share
|
Mar 15
2022 |
|
FRST
|
Clinton Tyler Stafford
Pres Panacea Financial |
BUY
Open market or private purchase
|
Direct | 740 Added 3.36% |
$10,552
$14.26 p/Share
|
Mar 15
2022 |
|
SRGA
|
David Lyle
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,200,000 Added 50.0% |
-
|
Mar 15
2022 |
|
CPSI
|
David A Dye
Director |
SELL
Open market or private sale
|
Indirect | 400 Reduced 0.78% |
$13,320
$33.3 p/Share
|
Mar 15
2022 |
|
TH
|
Troy C. Schrenk
SEVP, Operations & CCO |
SELL
Open market or private sale
|
Direct | 21,000 Reduced 45.28% |
$126,000
$6.0 p/Share
|
Mar 15
2022 |
|
TH
|
John Travis Kelley
EVP - Operations |
BUY
Open market or private purchase
|
Direct | 3,400 Added 17.44% |
$20,434
$6.01 p/Share
|
Mar 15
2022 |
|
BFLY
|
Larry Robbins
Director |
BUY
Open market or private purchase
|
Indirect | 500,000 Added 8.38% |
$2,250,000
$4.5 p/Share
|
Mar 15
2022 |
|
BBDC
|
Jeffrey Chillag
Director of Finance |
BUY
Other acquisition or disposition
|
Direct | 2,500 Added 33.91% |
$25,400
$10.16 p/Share
|
Mar 15
2022 |
|
OM
|
John L. Brottem
General Counsel |
SELL
Open market or private sale
|
Direct | 6,586 Reduced 15.18% |
$254,154
$38.59 p/Share
|
Mar 15
2022 |
|
OM
|
John L. Brottem
General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 6,586 Added 13.45% |
$62,435
$9.48 p/Share
|
Mar 15
2022 |
|
MYE
|
Frederic Jack Liebau Jr |
BUY
Open market or private purchase
|
Direct | 5,000 Added 8.92% |
$92,100
$18.42 p/Share
|
Mar 15
2022 |
|
MYE
|
Sarah R Coffin
Director |
BUY
Open market or private purchase
|
Direct | 500 Added 1.41% |
$9,185
$18.37 p/Share
|
Mar 15
2022 |
|
SPH
|
Bryon L Koepke
VP,General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 2,051 Reduced 2.76% |
$30,929
$15.08 p/Share
|
Mar 15
2022 |
|
AVDX
|
Michael Praeger
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 14,300 Added 0.16% |
$99,957
$6.99 p/Share
|
Mar 15
2022 |
|
AROC
|
Eric W Thode
SR VICE PRESIDENT |
BUY
Open market or private purchase
|
Indirect | 60 Added 30.77% |
$507
$8.45 p/Share
|
Mar 15
2022 |
|
KFRC
|
Ann E. Dunwoody
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 3,713 Added 19.71% |
-
|
Mar 15
2022 |
|
AKR
|
Wendy W Luscombe
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 2.79% |
$21,620
$21.62 p/Share
|
Mar 15
2022 |
|
ACLS
|
Dipti Vachani |
BUY
Grant, award, or other acquisition
|
Direct | 3,429 Added 50.0% |
-
|
Mar 15
2022 |
|
ACLS
|
Jeanne Quirk |
BUY
Grant, award, or other acquisition
|
Direct | 3,429 Added 50.0% |
-
|
Mar 15
2022 |
|
LKFN
|
James Rickard Donovan
SVP, General Counsel |
SELL
Open market or private sale
|
Direct | 525 Reduced 15.27% |
$43,050
$82.0 p/Share
|
Mar 15
2022 |
|
LKFN
|
Lisa M O'Neill
EVP & CFO |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 4.36% |
$102,812
$82.25 p/Share
|
Mar 15
2022 |
|
IIPR
|
Gary A Kreitzer |
SELL
Open market or private sale
|
Direct | 2,196 Reduced 7.27% |
$66,165
$30.13 p/Share
|
Mar 15
2022 |
|
CYTK
|
Mark A Schlossberg
SVP - Legal & General Counsel |
SELL
Open market or private sale
|
Direct | 25,196 Reduced 19.59% |
$855,656
$33.96 p/Share
|
Mar 15
2022 |
|
CYTK
|
Mark A Schlossberg
SVP - Legal & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 60,817 Added 32.11% |
$726,155
$11.94 p/Share
|
Mar 15
2022 |
|
GO
|
S. Mac Gregor Read Jr.
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,454 Added 8.23% |
-
|
Mar 15
2022 |
|
GO
|
Norman S Matthews
Director |
BUY
Grant, award, or other acquisition
|
Direct | 769 Added 2.09% |
-
|
Mar 15
2022 |
|
GO
|
Thomas F Herman
Director |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 4.21% |
$57,640
$28.82 p/Share
|
Mar 15
2022 |
|
GWRE
|
Jeffrey Elliott Cooper
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,546 Added 9.4% |
-
|
Mar 15
2022 |
|
GWRE
|
Priscilla Hung
President & COO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,655 Added 12.19% |
-
|
Mar 15
2022 |
|
GWRE
|
Michael Polelle
Chief Delivery Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,350 Added 13.19% |
-
|
Mar 15
2022 |
|
GWRE
|
Michael George Rosenbaum
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,063 Added 9.56% |
-
|
Mar 15
2022 |
|
LAD
|
Louis Miramontes
Director |
SELL
Open market or private sale
|
Direct | 250 Reduced 6.28% |
$80,257
$321.03 p/Share
|
Mar 15
2022 |
|
VTRS
|
Michael Goettler
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 50,352 Added 26.9% |
$496,974
$9.87 p/Share
|
Mar 15
2022 |
|
VTRS
|
W Don Cornwell |
BUY
Open market or private purchase
|
Direct | 2,700 Added 10.92% |
$26,730
$9.9 p/Share
|
Mar 15
2022 |
|
HSY
|
James C Katzman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 134 Added 1.66% |
$26,103
$194.8 p/Share
|
Mar 15
2022 |
|
HSY
|
Anthony J. Palmer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 173 Added 1.11% |
$33,700
$194.8 p/Share
|
Mar 15
2022 |
|
HSY
|
Juan R. Perez
Director |
BUY
Grant, award, or other acquisition
|
Direct | 20 Added 0.59% |
$3,896
$194.8 p/Share
|
Mar 15
2022 |